y 27632 has been researched along with Cerebral Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bath, PM; Bayraktutan, U; Gibson, CL; Sprigg, N; Srivastava, K | 1 |
| Asano, T; Hattori, T; Ikegaki, I; Kawasaki, K; Sasaki, Y; Satoh, S; Seto, M; Tawara, S; Toshima, Y; Yano, K | 1 |
2 other study(ies) available for y 27632 and Cerebral Infarction
| Article | Year |
|---|---|
Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Astrocytes; Blood-Brain Barrier; Blotting, Western; Brain Chemistry; Brain Ischemia; Cells, Cultured; Cerebral Infarction; Endothelial Cells; Functional Laterality; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Nerve Tissue Proteins; Oxidative Stress; Protein Kinase Inhibitors; Psychomotor Performance; Pyridines; Reactive Oxygen Species; rho-Associated Kinases; Tight Junctions | 2014 |
Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Activating Transcription Factor 3; Amides; Animals; Blotting, Western; Brain; Cerebral Cortex; Cerebral Infarction; Enzyme Inhibitors; Hippocampus; Immunohistochemistry; Male; Myosin Light Chains; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Tissue Extracts | 2008 |